Wellington Management Group
DSGN icon

Wellington Management Group’s Design Therapeutics DSGN Stock Holding History

Wellington Management Group’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-141,519
Closed -$546K – 1969
2025
Q1 		$546K Buy
+141,519
New +$675K ﹤0.01% 1810
2024
Q3 		– Sell
-256,627
Closed -$860K – 1939
2024
Q2 		$860K Buy
256,627
+42,317
+20% +$165K ﹤0.01% 1705
2024
Q1 		$864K Buy
+214,310
New +$572K ﹤0.01% 1716
2023
Q3 		– Sell
-502,375
Closed -$3.16M – 1828
2023
Q2 		$3.16M Sell
502,375
-47,957
-9% -$293K ﹤0.01% 1381
2023
Q1 		$3.18M Sell
550,332
-192,408
-26% -$1.44M ﹤0.01% 1393
2022
Q4 		$7.62M Sell
742,740
-206,033
-22% -$2.79M ﹤0.01% 1158
2022
Q3 		$15.9M Sell
948,773
-109,876
-10% -$2.19M ﹤0.01% 981
2022
Q2 		$14.8M Buy
1,058,649
+59,476
+6% +$803K ﹤0.01% 1022
2022
Q1 		$16.1M Buy
999,173
+143,635
+17% +$2.2M ﹤0.01% 1070
2021
Q4 		$18.3M Sell
855,538
-100,050
-10% -$1.72M ﹤0.01% 1103
2021
Q3 		$14M Buy
955,588
+16,226
+2% +$270K ﹤0.01% 1173
2021
Q2 		$18.5M Sell
939,362
-202,623
-18% -$5.11M ﹤0.01% 1111
2021
Q1 		$33.5M Buy
+1,141,985
New +$38.5M 0.01% 927

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Wellington Management Group's DSGN Position: Q2 2025 in Review

Wellington Management Group sold out of Design Therapeutics (DSGN) in Q2 2025, closing a stake of 141,519 shares — an estimated $546K sold.

Wellington Management Group first reported a position in DSGN in Q1 2021 and held it in 13 quarters. The position peaked at $33.5M in Q1 2021. 92 funds tracked by Wall St. Rank hold DSGN as of Q2 2025.

  • Wellington Management Group reported no remaining Design Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Wellington Management Group sold 141,519 Design Therapeutics shares in Q2 2025, an estimated $546K.
  • Wellington Management Group first reported a position in Design Therapeutics in Q1 2021 and held it in 13 quarters.
  • Wellington Management Group's Design Therapeutics position peaked at $33.5M in Q1 2021.
  • 92 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2025.

Based on Wellington Management Group's 13F filing for Q2 2025, filed 14 Aug 2025.